Quick Answer Psilocybin and other psychedelics show real, measurable promise for depression, particularly treatment-resistant cases. But the evidence in 2026 is more complicated, more honest, and more nuanced than headlines suggest. Whether this path is right for you...
Quick answer: A LSD For Anxiety randomized, placebo-controlled Phase 2b trial published in JAMA found that a single oral dose of MM120, an investigational LSD formulation developed by MindMed, produced significant reductions in generalized anxiety disorder symptoms...
The FDA rejected Lykos Therapeutics’ application for MDMA-assisted therapy for PTSD, citing three specific concerns: gaps in safety reporting, insufficient evidence that benefits lasted over time, and questions about who was enrolled in the trials. The MDMA...
A peer-reviewed study in npj Aging found that psilocybin and aging may be more connected than previously assumed, after treated female mice showed reduced oxidative stress, better-preserved telomeres, and longer lifespans than untreated controls. These are genuine...
Ketamine therapy preparation is not a formality you complete before the real thing begins. It is a functional part of what makes the treatment work. What you do before your session, how you move through it, and how you integrate what surfaces afterward determines...
An AI digital tripsitter is a software tool, usually an app or chatbot, designed to support psychedelic experiences through journaling prompts, intention-setting, and guided reflection. These tools offer genuine value in preparation and integration, but they carry...
